These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 38847690)
1. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods. Fu Z; Sun G; Li J; Yu H Medicine (Baltimore); 2024 Jun; 103(23):e38470. PubMed ID: 38847690 [TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes specific to pulmonary metastasis in osteosarcoma through integrated bioinformatics analysis. Chai Y; Xu L; He R; Zhong L; Wang Y Technol Health Care; 2022; 30(3):735-745. PubMed ID: 34542049 [TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma. Li J; Bai Y; Zhang H; Chen T; Shang G Front Immunol; 2024; 15():1445555. PubMed ID: 39324133 [TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related]
5. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis. Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370 [TBL] [Abstract][Full Text] [Related]
6. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling. Fan H; Lu S; Wang S; Zhang S Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206 [TBL] [Abstract][Full Text] [Related]
7. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis. Liu D; Zhou R; Zhou A Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541 [TBL] [Abstract][Full Text] [Related]
8. TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis. Ye JN; Gan MP; Wu XL; Dong Z; Mai HH Ann Clin Lab Sci; 2024 May; 54(3):299-312. PubMed ID: 39048164 [TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
10. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways. Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116 [TBL] [Abstract][Full Text] [Related]
11. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
14. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
15. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. Chen B; Sun D; Qin X; Gao XH Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609 [TBL] [Abstract][Full Text] [Related]
16. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy. He Y; Ma J; Ye X Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446 [TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma. Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739 [TBL] [Abstract][Full Text] [Related]
18. Combined bioinformatics and machine learning methodologies reveal prognosis-related ceRNA network and propose ABCA8, CAT, and CXCL12 as independent protective factors against osteosarcoma. Fan J; Liao J; Huang Y Adv Clin Exp Med; 2024 Aug; 33(8):857-868. PubMed ID: 38315381 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes. Feng L; Chen Y; Mei X; Wang L; Zhao W; Yao J Cancer Biother Radiopharm; 2024 Sep; 39(7):517-531. PubMed ID: 38512709 [No Abstract] [Full Text] [Related]
20. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis. Fang E; Zhang X Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]